Skip to main content
. 2020 May 8;10(5):907. doi: 10.3390/nano10050907

Figure 7.

Figure 7

In vivo time courses of PEGylated CF@MF nanoparticles after intravenous injection in balb/c mice: (a) liver (black) and muscle (grey), (b) kidneys (black) and muscle (grey).